Isle of Wight Nhs Primary Care Trust

SHIP PCT CLUSTER BOARD

ISLE OF WIGHT CLINICAL COMMISSIONING GROUP EXECUTIVE – CLINICAL STRATEGY BOARD (PEC)

TERMS OF REFERENCE

CONSTITUTION

The Isle of Wight Clinical Commissioning Group Executive Performance Board hereby resolves to establish a sub-committee of the Board to be known as the Clinical Commissioning Group Executive Clinical Strategy Board. It has those executive powers specifically delegated to it by the Cluster Board.

MAIN PURPOSE

To determine and oversee the strategy for commissioning health services to meet the needs of the Island population as delegated by the SHIP PCT Cluster Board, whilst working in partnership with stakeholders including the Local Authority.

MEMBERSHIP AND QUORUM

The membership of the Board will consist of:

Voting members:  Dr John Rivers (Chair)  Dr Sarah Bromley  Dr Peter Coleman  Dr Joanne Hesse  Dr David Isaac  Dr John Partridge (Deputy Chair)  Executive Director - Isle of Wight  Chief Finance Office – Isle of Wight  Director of Public Health / Chief Medical Advisor – Isle of Wight

Attendees:  Deputy Director (Commissioning & Partnerships)  Assistant Director (Contracting & Acute)  Head of Primary Care (Performance & Development)

A quorum shall be four members, of whom there should be three CCG GP Executives, and one of either the Executive Director or Chief Financial Officer.

Deputies may attend for non-GP Executive members in the absence of members and will be included for voting purposes.

Apologies for non-attendance should be sent to the PA to the Executive Director in advance of the meeting.

CCG Executive Clinical Strategy Board 1 October 2011 Terms of Reference v0.1

D:\Docs\2018-04-10\0e60e7a804d91c388898bc33da4c1bd5.doc FREQUENCY OF MEETINGS

Meetings shall normally be held monthly, with at least 10 meetings a year.

ATTENDANCE AT MEETINGS

It is agreed that all members should attend a minimum of 7 out of the 10 meetings per year.

DELEGATED AUTHORITY

The CCG Executive Clinical Strategy Board supports the CCG Executive Performance Board in the discharge of their responsibilities for the commissioning of health services for the Island population. The Board will operate within the existing delegated powers as detailed within the Cluster Scheme of Delegation, Standing Financial Instructions and Standing Orders.

DUTIES AND ADMINISTRATION

It is the duty of the Board to uphold the Code of Conduct for NHS Managers, which includes the seven principles of public life (The Nolan Committee), namely: Selflessness, integrity, objectivity, accountability, openness, honesty and leadership.

The Board shall be supported administratively by the PA to the Executive Director. The Terms of Reference are to be reviewed annually.

REPORTING ARRANGEMENTS

The minutes of the CCG Executive Clinical Strategy Board will be submitted to the CCG Executive Performance Board.

ROLE AND RESPONSIBILITIES

 Develop a clinical commissioning strategy  Lead on operational plan development  Oversee implementation of operational plan from clinical perspective  Oversee development of pathways/service design and specific clinical strategies  Review and implement NICE/NSFs/other guidance  Review work of locality groups  Develop and review work of GP clinical leads  Undertake leadership of the LTC QIPP schemes for 2011/12 and take leadership of the QIPP Plan for 2012/13  Develop mechanisms and ensure appropriate engagement with patients and the public

D:\Docs\2018-04-10\0e60e7a804d91c388898bc33da4c1bd5.doc Author:Helen Shields, Executive Director - Isle of Wight Review date: October 2012

D:\Docs\2018-04-10\0e60e7a804d91c388898bc33da4c1bd5.doc